Here is a list of 123 emerging and established Life Science companies that we keep track of. Those with an asterisk next to their name are companies that Stuart Roberts covered either at Southern Cross Equities / Bell Potter or at Baillieu Holst.
|
|
|
AdAlta (Melbourne, ASX: 1AD, www.adalta.com.au) is pioneering 'i-bodies' originally inspired by shark antibodies, with an initial focus on treating fibrotic diseases.
|
|
Adherium (Auckland, NZ, ASX: ADR, www.adherium.com). Developed the 'Smartinhaler', which tracks asthma medication compliance.
|
|
Admedus* (Brisbane, ASX: AHZ, www.admedus.com). Developer of tissue preparation and vaccine technology
|
|
AFT Pharmaceuticals (Auckland, NZ, ASX: AFP, www.aftpharm.com) manufactures various Rx and OTC products.
|
|
AirXpanders (Palo, Alto, Ca., ASX: AXP, www.airxpanders.com) is commercialising a tissue expander system for breast reconstruction.
|
|
Alcidion (Adelaide, ASX: ALC, www.alcidion.com.au) is a health informatics company.
|
|
Allegra Orthopaedics (Sydney, ASX: AMT, www.allegraorthopaedics.com) is a manufacturer of prosthetic implants.
|
|
Analytica (Brisbane, ASX: ALT, www.analyticamedical.com) is the developer of a device to treat stress urinary incontinence.
|
|
Anatara Lifesciences (Brisbane, ASX: ANR, www.anataralifesciences.com) develops oral solutions for gastrointestinal diseases.
|
|
Anteo Diagnostics* (Sydney, ASX: ADO, www.anteodx.com) is a surface design technology play, initially focused in diagnostics.
|
|
Antisense Therapeutics (Melbourne, ASX: ANP, www.antisense.com.au) is a gene modification technology developer.
|
|
AtCor Medical (Sydney and Itasca, Il., ASX: ACG, www.atcormedical.com) is a developer of blood pressure diagnostic systems.
|
|
AusCann (Perth, ASX: AC8, www.auscann.com.au) is a medicinal cannabis company.
|
|
Avita Medical (Northridge, Ca., ASX: AVH, www.avitamedical.com) is developing 'spray-on skin'.
|
|
Bard1 Life Sciences (Perth, ASX: BD1, www.bard1.com) is developing a lung cancer diagnostic that works by identifying the cancer biomarker Bard1.
|
|
Benitec Biopharma (Sydney, ASX: BLT, www.benitec.com) is a gene silencing technology developer.
|
|
Bionomics* (Adelaide, ASX: BNO, www.bionomics.com.au) is a drug design house.
|
|
Biotron* (Sydney, ASX: BIT, www.biotron.com.au) is an anti-viral drug developer.
|
|
Bioxyne (Sydney, ASX: BXN, www.bioxyne.com) is a developer of probiotics.
|
|
BLIS Technologies (Dunedin, New Zealand, NZX: BLT, www.blisprobiotic.com) is a developer of probiotics.
|
|
Botanix Pharmaceuticals (Radnor, Pa., ASX: BOT, www.botanixpharma.com) is a developer of cannabinoid-based therapeutics for skin diseases.
|
|
Brain Resource* (Sydney, ASX: BRC, www.brainresource.com) is the owner of the world's largest brain function database.
|
|
Cellmid* (Sydney, ASX: CDY, www.cellmid.com.au) is working on drugs that target midkine, a heparin-binding growth factor.
|
|
Clinuvel Pharmaceuticals (Melbourne, ASX: CUV, www.clinuvel.com) develops of drugs to treat skin disorders.
|
|
Clover Corporation (Sydney, ASX: CLV, www.clovercorp.com.au) is a supplier of nutritional and functional ingredients for food.
|
|
Cochlear (Sydney, ASX: COH, www.cochlear.com) pioneered the cochlear implant which is routinely used these days to treat sensorineural hearing loss.
|
|
Cogstate (Melbourne, ASX: CGS, www.cogstate.com) is a brain function company.
|
|
Compumedics (Melbourne, Australia, ASX: CMP, www.compumedics.com) is a developer of devices to measure brain function.
|
|
Creso Pharma (Perth, Australia, ASX: CPH, www.cresopharma.com.) is a medicinal cannabis company.
|
|
CSL Ltd (Melbourne, ASX: CSL, www.csl.com.au). This company, which originated as an entity owned by the Australian government called the Commonwealth Serum Laboratories, is today one of the 50 largest pharma companies in the world, with a franchise based on plasma products.
|
|
Cyclopharm (Sydney, ASX: CYC, www.cyclopharm.com.au) is a supplier of radiopharmaceuticals.
|
|
Cynata Therapeutics* (Melbourne, ASX: CYP, www.cynata.com) is a stem cell company.
|
|
Dimerix (Perth, ASX: DXB, www.dimerix.com) is a developer of drugs that target G-protein coupled receptors, focused on kidney disorders.
|
|
dorsaVi (Melbourne, ASX: DVL, www.dorsavi.com) is a developer of orthopedic implants.
|
|
Ellex Medical Lasers (Adelaide, ASX: ELX, www.ellex.com) is a supplier of medical lasers for ophthalmology.
|
|
eSense-Lab (Ness Ziona, Israel, ASX: ESE, www.esense-lab.com) reverse engineers rare or lucrative plants in order to reconstruct their chemical profile and create alternate natural products.
|
|
EVE Investments (Perth, ASX: EVE, www.eveinvestments.com.au) is investing in Omniblend Innovation, a medical food technology company.
|
|
Factor Therapeutics* (Brisbane, ASX: FTT, www.factor-therapeutics.com) is a developer of wound healing technology.
|
|
Fisher & Paykel Healthcare* (Auckland, NZ, ASX: FPH, www.fphcare.com) supplies products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea.
|
|
Genera Biosystems (Melbourne, ASX: GBI, www.generabiosystems.com) is a molecular diagnostics company.
|
|
Genetic Signatures (Sydney, ASX: GSS, www.geneticsignatures.com) develops of rapid PCR-based diagnostics.
|
|
Genetic Technologies (Melbourne, ASX: GTG, www.gtg.com.au) is monetising key patents over non-coding DNA.
|
|
GI Dynamics* (Lexington, Ma., ASX: GID, www.gidynamics.com) is the developer of a device to treat obesity and Type II diabetes.
|
|
Holista CollTech (Perth, Australia, ASX: HCT, www.holistaco.com) is a collagen production technology company.
|
|
IDT Australia (Melbourne, ASX: IDT, www.idtaus.com.au) is a Contract Research Organisation.
|
|
Immuron (Melbourne, ASX: IMC, www.immuron.com) is a developer of dairy-derived polyclonal antibodies for immunotherapy.
|
|
Impedimed (Brisbane, and Carlsbad, Ca., ASX: IPD, www.impedimed.com.au) is commercialising a lymphedema diagnostic.
|
|
Imugene (Melbourne, ASX: IMU, www.imugene.com) is developing peptide vaccines for cancer immunotherapy.
|
|
Innate Immunotherapeutics (Auckland, NZ, ASX: IIL, www.innateimmunotherapeutics.com) is working an an MS treatment.
|
|
Invion (Brisbane, ASX: IVX, www.invion.com.au) is focused on repurposing of old drugs to treat respiratory disorders.
|
|
InvitroCue (Singapore, ASX: IVQ, www.invitrocue.com) is a provider of bioanalytics services.
|
|
Jayex Healthcare (Melbourne, Australia, ASX: JHL, www.jayexhealthcare.com.au) develops healthcare self-service solutions as well as software for patient flow management.
|
|
Kazia Therapeutics (Sydney, Australia, ASX: KZA, www.kaziatherapeutics.com) is developing a PI3K inhibitor for the treatment of glioblastoma.
|
|
LBT Innovations (Adelaide, ASX: LBT, www.lbtinnovations.com) develops automated solutions for microbiological culture.
|
|
Leaf Resources (Perth, ASX: LER, www.leafresources.com.au) has technology to convert biomass into industrial sugars.
|
|
LifeHealthcare (Sydney, ASX: LHC, www.lifehealthcare.com.au) is a distributor of medical equipment.
|
|
Lifespot Health (Melbourne, Australia, ASX: LSH, www.lifespot-health.com) develops smartphone-based diagnostics.
|
|
Living Cell Technologies (Auckland, NZ, ASX: LCT, www.lctglobal.com). This xenotransplantation company focused on Parkinson's Disease.
|
|
Mach7 Technologies (Melbourne, ASX: M7T, www.mach7t.com) develops enterprise imaging solutions.
|
|
Mayne Pharma (Adelaide, ASX: MYX, www.maynepharma.com) is a generic drug company.
|
|
MedAdvisor (Melbourne, ASX: MDR, www.medadvisor.com.au). This company develops software helping pharmacists and doctors to remind patients when and how to take their medicines.
|
|
Medibio* (Sydney, ASX: MEB, www.medibio.com.au) is a developer of new mental health diagnostics.
|
|
Medical Developments (Melbourne, ASX: MVP, www.medicaldev.com) supplies the pain drug methoxyflurane.
|
|
Medlab Clinical (Sydney, ASX: MDC, www.medlab.co) is working on probiotic bacteria as well as nanotech-based drug delivery.
|
|
MGC Pharmaceuticals (Perth, ASX: MXC, www.mgcpharma.com.au) is a medical cannabis company.
|
|
Mesoblast* (Melbourne, ASX: MSB, www.mesoblast.com.au) is the world's leading stem cell company.
|
|
Micro-X (Adelaide, ASX: MX1, www.micro-x.com) is developing an ultra-lightweight medical x-ray.
|
|
MMJ Phytotech (Perth, ASX: MMJ,www.mmjphytotech.com.au) is a medical cannabis company.
|
|
Nanollose (Perth, ASX: NC6, www.nanollose.com) produces fibres using a fermentation process that provides an alternative to plant-derived cellulose fibres.
|
|
Nanosonics (Sydney, ASX: NAN, www.nanosonics.com.au). This company's trophon EPR product disinfects ultrasound probes at low temperatures using ‘nanonebulant’ technology.
|
|
Neuren Pharmaceuticals* (Melbourne, ASX: NEU, www.neurenpharma.com) is a developer of neuroprotection drugs.
|
|
Neurotech International (Perth, ASX: NTI, www.neurotechinternational.com) develops neurofeedback systems for the home-based treatment of people with autism spectrum disorders.
|
|
Novita Healthcare (Melbourne, ASX: NHL, www.novitahealthcare.com.au) is working on a computerised program for improving childhood attention difficulties.
|
|
Noxopharm (Sydney, ASX: NOX, www.noxopharm.com) is a cancer drug developer.
|
|
Nuheara (Perth, ASX: NUH, www.nuheara.com) is a developer of intelligent hearing devices.
|
|
OBJ Ltd (Perth, ASX: OBJ, www.obj.com.au) is a transdermal drug delivery company.
|
|
OncoSil Medical* (Sydney, ASX: OSL, www.oncosil.com.au) is a developer of localised radiation therapy devices.
|
|
Opthea (Melbourne, ASX: OPT, www.opthea.com) is a developer of VEGF-blockers for the treatment of eye diseases.
|
|
Optiscan Imaging (Melbourne, ASX: OIL, www.opticsan.com) develops miniaturised confocal microscopes.
|
|
Orion Health (Auckland, NZ, ASX: OHE, www.orionhealth.com) is a developer of healthcare information technology.
|
|
Orthocell (Perth, ASX: OCC, www.orthocell.com.au) is a stem cell company.
|
|
Osprey Medical (Eden Prairie, Mn., ASX: OSP, www.ospreymed.com) has developed a device to treat contract-induced nephropathy.
|
|
Oventus Medical (Brisbane, ASX: OVN, www.oventus.com) is developing a device for the treatment of sleep-disordered breathing.
|
|
Pacific Edge (Dunedin, NZ, NZX: PEB, www.pacificedge.co.nz) develops RNA-based cancer diagnostics.
|
|
PainChek (Sydney, ASX: PCK, www.painchek.com) is developing a mobile app that rapidly detects pain using facial recognition technology and smartphones.
|
|
Paradigm Biopharma (Melbourne, ASX: PAR, www.paradigmbiopharma.com) is repurposing pentosan polysulphate sodium.
|
|
Patrys* (Sydney, ASX: PAB, www.patrys.com.au) is a cancer antibody drug developer.
|
|
PharmAust (Perth, ASX: PAA, www.pharmaust.com) is a cancer drug developer.
|
|
Pharmaxis (Sydney, ASX: PXS, www.pharmaxis.com.au) is a developer of drugs for respiratory diseases.
|
|
Phosphagenics* (Melbourne, ASX: POH, www.phosphagenics.com) is a transdermal drug delivery company.
|
|
Phylogica (Perth, ASX: PYC, www.phylogica.com.au) is a peptide drug discovery company.
|
|
PolyNovo (Melbourne, ASX: PNV, www.polynovo.com.au) is a developer of biodegradable polymer technology.
|
|
Prana Biotechnology* (Melbourne, ASX: PBT, www.pranabio.com) is an Alzheimer's drug developer.
|
|
Probiotec (Melbourne, ASX: PBP, www.probiotec.com.au) is a supplier of dietary supplements.
|
|
Proteomics International (Perth, ASX: PIQ, www.proteomics.com.au) is a provider of proteomics services that also works on biomarker discovery.
|
|
Promisia Integrative (Wellington, NZ, NZX: PIL, www.promisia.com) is a developer of dietary supplements.
|
|
RACE Oncology (Melbourne, ASX: RAC, www.raceoncology.com) is developing bisantrene for the treatment of Acute Myleoid Leukaemia.
|
|
Recce (Perth, ASX: RCE, www.recce.com.au) is a developer of new-generation antibiotics.
|
|
Regeneus (Sydney, ASX: RGS, www.regeneus.com.au) is a stem cell and cancer immunotherapy company.
|
|
ResApp Health (Perth, ASX: RAP, www.resapphealth.com.au) is a developer of a smartphone app for respiratory disease diagnosis.
|
|
Resonance Health (Perth, ASX: RHT, www.resonancehealth.com) is developing FerriScan, widely recognised as the leading technology for quantitative measurement of liver iron overload.
|
|
Respiri (Melbourne, ASX: RSH, www.respiri.co) is developing a lung function diagnostic.
|
|
REVA Medical* (San Diego, Ca., ASX: RVA, www.teamreva.com) is developing a bioresorbable stents.
|
|
Rhinomed* (Melbourne, ASX: RNO, www.rhinomed.com.au) is developing of a nasal device to improve upper airway patency.
|
|
Rhythm Biosciences (Melbourne, ASX: RHY, www.rhythmbio.com) is developing a blood test for colorectal cancer called ColoSTAT which assays a number of relevant biomarkers.
|
|
Sea Dragon (Nelson, NZ, NZX: SEA, www.seadragon.co.nz) is a producer of Omega-3 fish oil.
|
|
Sienna Cancer Diagnostics (Melbourne, ASX: SDX, www.siennadiagnostics.com.au) is a molecular diagnostics company.
|
|
Simavita (Sydney, ASX: SVA, www.simavita.com) has developed a medical device for urinary incontinence assessment and management.
|
|
SomnoMed (Sydney, ASX: SOM, www.somnomed.com) is a supplier of oral devices for the treatment of sleep apnea.
|
|
Starpharma* (Melbourne, ASX: SPL, www.starpharma.com) is commercialising a class of molecule called the dendrimer.
|
|
SUDA Pharmaceuticals (Perth, ASX: SUD, www.sudapharma.com) is a drug delivery company.
|
|
TBG Diagnostics (Melbourne, ASX: TDL, www.tbgbio.com) is a molecular diagnostics company.
|
|
The Hydroponics Company (Sydney, ASX: THC, www.thcl.com.au) is a medicinal cannabis company.
|
|
Universal Biosensors (Melbourne, ASX: UBI, www.universalbiosensors.com) is a diagnostics company.
|
|
Uscom (Sydney, ASX: UCM, www.uscom.com.au) is a developer of products to measure cardiovascular function.
|
|
Vectus Biosystems (Sydney, ASX: VBS, www.vectusbiosystems.com.au) is working on drugs to treat cardiovascular fibrosis and high blood pressure.
|
|
Visioneering Technologies (Alpharetta, Ga, ASX: VTI, www.vtivision.com) develops products to treat eye conditions such as presbyopia, myopia and astigmatism.
|
|
Volpara Health Technologies (Wellington, New Zealand, ASX: VHT, www.volparasolutions.com) is developing a digital breast cancer diagnostic.
|
|
Zelda Therapeutics (Perth, Australia, ASX: ZLD, www.zeldatherapeutics.com) is a medicinal cannabis company.
|
|
Zoono (Auckland, NZ, ASX: ZNO, www.zoono.com) is a developer of anti-microbial products.
|
Copyright © 2018 NDF Research
